222 studies found for:    Open Studies | "Fatty Acids, Omega-3"
Show Display Options
Rank Status Study
21 Unknown  Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children
Conditions: Lifestyle-related Condition;   Overweight and Obesity;   Essential Fatty Acid Deficiency
Interventions: Dietary Supplement: Omega-3;   Dietary Supplement: Placebo
22 Recruiting OmegaChild - Omega-3 Supplementation to Children Previously Treated for Cancer
Condition: Pediatric Cancer
Intervention: Dietary Supplement: Omega-3 enriched fruit juice
23 Recruiting Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3
Condition: Hyperlipidemia
Interventions: Drug: Omega-3-acid ethyl esters;   Drug: Standard antihyperlipidemic therapy other than administration of omega-3 fatty acid ethyl esters (Lotriga).
24 Not yet recruiting Lipoic Acid and Omega-3 Fatty Acids for Cognitive Impairment in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Cognition
Interventions: Drug: Alpha lipoic acid and omega-3 fatty acids;   Drug: Placebo
25 Unknown  The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Dietary Supplement: Omega 3;   Other: Physical Training
26 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
27 Recruiting n-3 PUFA for Vascular Cognitive Aging
Conditions: Age Related Cognitive Decline;   Alzheimer's Disease;   Vascular Dementia;   Endothelial Dysfunction;   Executive Dysfunction
Interventions: Drug: Omega 3 PUFA;   Drug: Placebo
28 Recruiting A PK and PD Study of Two Formulations of Omega-3 One Gram Capsules
Condition: Hypertriglyceridemia
Interventions: Drug: Drug Omega 3;   Drug: Drug Omega-3 Comparator
29 Unknown  The Effect of Omega-3 Fatty Acid Supplementation on Skeletal Muscle Membrane Composition and Cellular Metabolism
Condition: Skeletal Muscle Energy Metabolism
Interventions: Dietary Supplement: Omega-3 Complete;   Dietary Supplement: Placebo Pill
30 Recruiting Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function
Condition: Morbid Obesity
Interventions: Drug: Omega-3 fatty acid capsules;   Behavioral: Low calorie diet
31 Not yet recruiting The Correlation Between Blood omega3 and ADHD
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Procedure: blood test;   Dietary Supplement: omega3 capsules
32 Recruiting Omega-3 Supplementation for Smell Dysfunction
Conditions: Sellar/Parasellar Tumor;   Smell Dysfunction
Intervention: Dietary Supplement: Omega-3
33 Recruiting Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy
Conditions: Attention Deficit Disorder With Hyperactivity;   ADHD Inattention or Mixed Type;   Epilepsy;   Child
Interventions: Drug: Vayarin®, supplementation of n-3 PUFA;   Drug: PLACEBO
34 Unknown  Feasibility of Omega-3 Supplementation for Children With Language Impairments
Condition: Language Impairment
Interventions: Dietary Supplement: Omega-3;   Dietary Supplement: Placebo
35 Recruiting Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Condition: Hyperlipidemia, Familial Combined
Interventions: Drug: Atorvastatin 20mg;   Drug: Omega-3-acids ethylesters 90 4g;   Other: Placebo(Omega-3-acids ethylesters 90)
36 Unknown  Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
Condition: Autism
Interventions: Dietary Supplement: Omega 3 fatty acids;   Other: Placebo
37 Not yet recruiting Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
Conditions: Major Depressive Disorder;   Obesity;   Inflammation
Interventions: Other: Placebo;   Drug: EPA 1 g/day;   Drug: EPA 2 g/day;   Drug: EPA 4 g/day
38 Unknown  Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)?
Condition: Coronary Arteriosclerosis
Intervention: Drug: omega 3
39 Recruiting Effect of Mother's Supplementation Omega-3 in the Dynamics of Fetal Ductus Arteriosus: a Randomized Clinical Trial.
Condition: Pregnancy
Interventions: Dietary Supplement: Omega 3;   Dietary Supplement: Soy Oil
40 Unknown  Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?
Condition: Coronary Atherosclerosis
Intervention: Dietary Supplement: Omega 3

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years